Xiaojie Zhang, MD, and Akshat Singhal, PhD, discuss their research leveraging deep learning to predict how patients with ER+/HER2- breast cancer will respond to palbociclib.
Xiaojie Zhang, MD
Xiaojie Zhang, MD, a hematology/oncology fellow at UC San Diego.
Articles by Xiaojie Zhang, MD